HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naohiro Oda Selected Research

pembrolizumab

7/2022Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801.
7/2021Successful treatment of critical coronavirus disease 2019 in a patient with lung cancer concomitant with pembrolizumab-induced arthritis by methylprednisolone, baricitinib, and remdesivir.
7/2020Successful Treatment of Non-small-cell Lung Cancer with Atezolizumab Following Tubulointerstitial Nephritis Due to Pembrolizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naohiro Oda Research Topics

Disease

23Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 01/2016
11Lung Neoplasms (Lung Cancer)
01/2024 - 12/2014
8Neoplasms (Cancer)
02/2024 - 11/2016
5Disease Progression
12/2022 - 11/2016
5Inflammation (Inflammations)
11/2021 - 01/2017
3Exanthema (Rash)
03/2024 - 01/2016
3Carcinoma (Carcinomatosis)
02/2024 - 01/2017
3COVID-19
01/2023 - 07/2021
3Interstitial Lung Diseases (Interstitial Lung Disease)
01/2023 - 01/2022
3Asthma (Bronchial Asthma)
01/2023 - 01/2017
3Pneumonia (Pneumonitis)
01/2022 - 01/2021
3Emphysema
01/2022 - 01/2019
3Idiopathic Pulmonary Fibrosis
11/2021 - 01/2020
3Chronic Obstructive Pulmonary Disease (COPD)
05/2021 - 01/2017
3Lymphadenopathy
10/2020 - 06/2016
2Fever (Fevers)
01/2023 - 01/2022
2Allergic Bronchopulmonary Aspergillosis
01/2023 - 10/2018
2Fibrosis (Cirrhosis)
12/2022 - 11/2021
2Pulmonary Fibrosis (Fibrosing Alveolitis)
12/2022 - 11/2021
2Pulmonary Emphysema
01/2022 - 01/2019
2Adenocarcinoma of Lung
07/2020 - 12/2014
2Diarrhea
12/2018 - 01/2016
1Bullous Pemphigoid (Pemphigoid)
03/2024
1Hyperglycemia
03/2024
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
03/2024
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2024
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2024
1Type 2 Diabetes Mellitus (MODY)
03/2024
1Disseminated Intravascular Coagulation
03/2023
1Spotted Fever Group Rickettsiosis (Rickettsialpox)
03/2023
1Septic Shock (Toxic Shock Syndrome)
03/2023
1Infections
01/2023
1Pleural Effusion (Pleural Effusions)
12/2022
1Respiratory Insufficiency (Respiratory Failure)
11/2022
1Myositis (Idiopathic Inflammatory Myopathies)
11/2022
1Esophageal Stenosis (Esophageal Stricture)
04/2022
1Lymphatic Metastasis
04/2022
1Esophageal Neoplasms (Esophageal Cancer)
04/2022
1Dyspnea (Shortness of Breath)
01/2022
1Headache (Headaches)
01/2022
1Hypoxia (Hypoxemia)
01/2022
1Anaphylaxis (Anaphylactic Shock)
01/2022
1Pain (Aches)
01/2022
1Adenocarcinoma
09/2021
1Neoplasm Metastasis (Metastasis)
09/2021

Drug/Important Bio-Agent (IBA)

14Immune Checkpoint InhibitorsIBA
03/2024 - 01/2020
7ErbB Receptors (EGF Receptor)IBA
01/2021 - 12/2014
4Tyrosine Kinase InhibitorsIBA
12/2018 - 01/2016
3Adrenal Cortex Hormones (Corticosteroids)IBA
03/2024 - 06/2019
3Neuropeptide YIBA
12/2022 - 01/2019
3LigandsIBA
07/2022 - 01/2020
3pembrolizumabIBA
07/2022 - 07/2020
3Cisplatin (Platino)FDA LinkGeneric
01/2022 - 01/2021
3durvalumabIBA
01/2022 - 01/2021
3Pancreatic Elastase (Elastase)IBA
01/2022 - 01/2019
3AfatinibIBA
12/2018 - 01/2016
3Gefitinib (Iressa)FDA Link
11/2016 - 12/2014
2atezolizumabIBA
03/2024 - 07/2020
2InterleukinsIBA
01/2023 - 05/2021
2Bleomycin (Blenoxane)FDA LinkGeneric
12/2022 - 11/2021
2AntibodiesIBA
11/2022 - 01/2020
2B7-H1 AntigenIBA
12/2021 - 02/2021
2Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 01/2021
2Interleukin-17 (Interleukin 17)IBA
11/2021 - 01/2019
2SmokeIBA
05/2021 - 01/2019
2AntigensIBA
05/2021 - 06/2019
2Programmed Cell Death 1 ReceptorIBA
02/2021 - 01/2020
2Retinoid X Receptors (Retinoid X Receptor)IBA
01/2019 - 01/2017
1Insulin (Novolin)FDA Link
03/2024
1Hypoglycemic Agents (Hypoglycemics)IBA
03/2024
1Nuclear Proteins (Protein, Nuclear)IBA
02/2024
1alpha-Fetoproteins (alpha-Fetoprotein)IBA
02/2024
1Dacarbazine (DIC)FDA LinkGeneric
03/2023
1Monoclonal AntibodiesIBA
01/2023
1geranylgeranylacetone (teprenone)IBA
01/2023
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2023
1TriazolesIBA
01/2023
1Interleukin-5 Receptors (Interleukin 5 Receptor)IBA
01/2023
1neuropeptide Y-Y1 receptorIBA
12/2022
1asparaginyl-tRNA synthetaseIBA
11/2022
1Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2022
1Transfer RNA (tRNA)IBA
11/2022
1BNT162 VaccineIBA
01/2022
1VaccinesIBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1mRNA VaccinesIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
12/2021
1Interleukin-23 (Interleukin 23)IBA
11/2021
1LipopolysaccharidesIBA
11/2021
1CytokinesIBA
11/2021
1Paclitaxel (Taxol)FDA LinkGeneric
09/2021

Therapy/Procedure

13Therapeutics
03/2024 - 12/2014
7Drug Therapy (Chemotherapy)
03/2024 - 11/2016
6Radiotherapy
01/2022 - 12/2014
3Chemoradiotherapy
01/2022 - 01/2021
2Immunotherapy
01/2024 - 09/2023
1Extracorporeal Membrane Oxygenation
11/2022
1Bronchoscopes
04/2022